Company intelligence / Profile preview

Epi-Ret

Giessen, Hesse, Germany
Ownership
Private
Development stage
Other
01

Overview

Epi-Ret was a German medical technology company focused on the development of epiretinal prostheses to restore vision in patients with degenerative retinal diseases. The company's flagship product, the Epi-Ret 3, was a fully implantable, wireless retinal stimulator designed to bypass damaged photoreceptors and directly stimulate retinal ganglion cells. Developed through a multi-institutional consortium in Germany, the device aimed to provide functional vision to individuals blinded by conditions such as retinitis pigmentosa. The system was unique for its wireless design, which eliminated the need for trans-scleral cables, potentially reducing surgical complications. While the technology demonstrated technical feasibility in early clinical trials, the company is no longer active in the commercial market.

Therapeutic areas
Ophthalmology
Modalities
Device
Industry
Implantable Medical Devices
02

Partnerships

University of BonnRWTH Aachen UniversityFraunhofer Institute for Microelectronic Circuits and SystemsUniversity of Duisburg-Essen

Beyond the preview

Go deeper on Epi-Ret.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Epi-Ret.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call